Application of proteomics to prenatal screening and diagnosis for aneuploidies

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 1, 2011, Pages 33-41

  Cho, Chan Kyung J ^a,b   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Aneuploidy; Biomarker discovery; Down syndrome; Mass spectrometry; Prenatal screening; Proteomics

Indexed keywords

BIOLOGICAL MARKER; DNA; PROTEOME;

AMNION FLUID; ANEUPLOIDY; BODY FLUID; DIAGNOSTIC TEST; DOWN SYNDROME; EDWARDS SYNDROME; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; MASS SPECTROMETRY; MATERNAL PLASMA; PATAU SYNDROME; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY 13; TRISOMY 18; URINALYSIS; UTERINE CERVIX;

ANEUPLOIDY; BIOLOGICAL MARKERS; FEMALE; HUMANS; MASS SPECTROMETRY; PREGNANCY; PRENATAL DIAGNOSIS; PROTEOMICS;

EID: 79953156278     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.002     Document Type: Review

References (71)

1. Papp C, Papp Z. Chorionic villus sampling and amniocentesis: what are the risks in current practice? Curr Opin Obstet Gynecol 2003;15:159-65. (Pubitemid 36432884)
2. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11. (Pubitemid 41609093)
3. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988;95:330-3.
4. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alphafetoprotein measurement: a screening test for Down syndrome. Lancet 1984;1:926-9. (Pubitemid 14136296)
5. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94. (Pubitemid 14125705)
6. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987;94:387-402. (Pubitemid 17068086)
7. Haddow JE, Knight GJ, Palomaki GE. Prenatal ultrasound screening and perinatal outcome. N Engl J Med 1994;330:571; author reply-2.
8. Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992;12:801-6.
9. Wald N, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B, et al. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. Br Med J 1992;305:28.
10. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 1997;17:821-9. (Pubitemid 27384797)
11. Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006;76:747-56.
12. Knight GJ, Palomaki GE, Neveux LM, Smith DE, Kloza EM, Pulkkinen AJ, et al. Integrated serum screening for Down syndrome in primary obstetric practice. Prenat Diagn 2005;25:1162-7. (Pubitemid 43016300)
13. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104. (Pubitemid 36734906)
14. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7:1-77.
15. Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009;200:459 e1-9.
16. Halliday JL, Watson LF, Lumley J, Danks DM, Sheffield LJ. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age from a uniquely defined population. Prenat Diagn 1995;15:455-65.
17. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
18. Haynes PA, Yates JR 3rd. Proteome profiling-pitfalls and progress. Yeast 2000;17:81-7. (Pubitemid 30466086)
19. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-67.
20. Nagalla SR, Canick JA, Jacob T, Schneider KA, Reddy AP, Thomas A, et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J Proteome Res 2007;6:1245-57. (Pubitemid 46724021)
21. Kolialexi A, Tsangaris GT, Papantoniou N, Anagnostopoulos AK, Vougas K, Bagiokos V, et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat Diagn 2008;28:691-8.
22. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004;3:1154-69.
23. Kolla V, Jeno P, Moes S, Tercanli S, Lapaire O, Choolani M, et al. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol 2010;2010:952047.
24. Kentsis A, Lin YY, Kurek K, Calicchio M, Wang YY, Monigatti F, et al. Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med 2010;55:62-70 e4.
25. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006;7:R80.
26. Oh J, Pyo JH, Jo EH, Hwang SI, Kang SC, Jung JH, et al. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 2004;4:3485-97. (Pubitemid 39525299)
27. Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004;4:1159-74. (Pubitemid 38445973)
28. Smith MP, Banks RE, Wood SL, Lewington AJ, Selby PJ. Application of proteomic analysis to the study of renal diseases. Nat Rev Nephrol 2009;5:701-12.
29. Huggins GR, Preti G. Vaginal odors and secretions. Clin Obstet Gynecol 1981;24:355-77. (Pubitemid 12133122)
30. Dasari S, Pereira L, Reddy AP, Michaels JE, Lu X, Jacob T, et al. Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 2007;6:1258-68. (Pubitemid 46724022)
31. Pereira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007;6:1269-76. (Pubitemid 46724023)
32. Shaw JL, Smith CR, Diamandis EP. Proteomic analysis of human cervico-vaginal fluid. J Proteome Res 2007;6:2859-65. (Pubitemid 47122380)
33. Di Quinzio MK, Georgiou HM, Holdsworth-Carson SJ, Ayhan M, Heng YJ, Walker SP, et al. Proteomic analysis of human cervico-vaginal fluid displays differential protein expression in association with labor onset at term. J Proteome Res 2008;7:1916-21.
34. Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intraamniotic inflammation. J Proteome Res 2005;4:2236-42. (Pubitemid 41814292)
35. Liberatori S, Bini L, De Felice C, Magi B, Marzocchi B, Raggiaschi R, et al. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 1997;18:2816-22. (Pubitemid 28059954)
36. Nilsson S, Ramstrom M, Palmblad M, Axelsson O, Bergquist J. Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 2004;3:884-9. (Pubitemid 39166252)
37. Park SJ, Yoon WG, Song JS, Jung HS, Kim CJ, Oh SY, et al. Proteome analysis of human amnion and amniotic fluid by twodimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics 2006;6:349-63. (Pubitemid 43142958)
38. Tsangaris GT, Kolialexi A, Karamessinis PM, Anagnostopoulos AK, Antsaklis A, Fountoulakis M, et al. The normal human amniotic fluid supernatant proteome. In Vivo 2006;20:479-90. (Pubitemid 44184104)
39. Queloz PA, Crettaz D, Thadikkaran L, Sapin V, Gallot D, Jani J, et al. Proteomic analyses of amniotic fluid: potential applications in health and diseases. J Chromatogr B Analyt Technol Biomed Life Sci 2007;850:336-42. (Pubitemid 46618180)
40. Michaels JE, Dasari S, Pereira L, Reddy AP, Lapidus JA, Lu X, et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J Proteome Res 2007;6:1277-85. (Pubitemid 46724024)
41. Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 2007;6:1406-15. (Pubitemid 47365438)
42. Wang JC, Bowser K, Chernos J. Shedding new light on false positive diagnosis of trisomy 21 by fluorescence in situ hybridization (FISH) on uncultured amniotic fluid cells: experiences from two Canadian cytogenetic laboratories. Prenat Diagn 2007;27:964-6. (Pubitemid 47597926)
43. Oh JE, Fountoulakis M, Juranville JF, Rosner M, Hengstschlager M, Lubec G. Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics 2004;4:1145-58. (Pubitemid 38445972)
44. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 2006;6:4410-9. (Pubitemid 44277042)
45. Mange A, Desmetz C, Bellet V, Molinari N, Maudelonde T, Solassol J. Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids. Proteome Sci 2008;6:1.
46. Wang TH, Chao AS, Chen JK, Chao A, Chang YL, Cheng PJ, et al. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil Steril 2009;92:96-107.
47. Cho CK, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J Proteome Res 2010;9:3574-82.
48. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990;87:3279-83. (Pubitemid 20173618)
49. Herzenberg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence- activated cell sorting. Proc Natl Acad Sci USA 1979;76:1453-5. (Pubitemid 9136883)
50. Beroud C, Karliova M, Bonnefont JP, Benachi A, Munnich A, Dumez Y, et al. Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells. Lancet 2003;361:1013-4. (Pubitemid 36351371)
51. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92. (Pubitemid 38125703)
52. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75. (Pubitemid 28194317)
53. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-2. (Pubitemid 30104263)
54. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360:998-1000. (Pubitemid 35284114)
55. Ding C, Chiu RW, Lau TK, Leung TN, Chan LC, Chan AY, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004;101:10762-7. (Pubitemid 38955816)
56. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002;346:1502. (Pubitemid 34755726)
57. Rijnders RJ, Christiaens GC, Bossers B, van der Smagt JJ, van der Schoot CE, de Haas M. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004;103:157-64. (Pubitemid 39248481)
58. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51:1598-604. (Pubitemid 41233093)
59. Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood M, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. J Am Med Assoc 2004;291:1114-9. (Pubitemid 38541689)
60. Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007;369:474-81. (Pubitemid 46217810)
61. Avent ND, Plummer ZE, Madgett TE, Maddocks DG, Soothill PW. Post-genomics studies and their application to non-invasive prenatal diagnosis. Semin Fetal Neonatal Med 2008;13:91-8.
62. Pont-Kingdon G, Lyon E. Rapid detection of aneuploidy (trisomy 21) by allele quantification combined with melting curves analysis of single-nucleotide polymorphism loci. Clin Chem 2003;49:1087-94. (Pubitemid 36751095)
63. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218-23.
64. Hamlington J, Cunningham J, Mason G, Mueller R, Miller D. Prenatal detection of rhesus D genotype. Lancet 1997;349:540.
65. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46:1832-4.
66. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002;48:1212-7. (Pubitemid 34809828)
67. Kido S, Sakuragi N, Bronner MP, Sayegh R, Berger R, Patterson D, et al. D21S418E identifies a cAMP-regulated gene located on chromosome 21q22.3 that is expressed in placental syncytiotrophoblast and choriocarcinoma cells. Genomics 1993;17:256-9. (Pubitemid 23205092)
68. Tsui NB, Akolekar R, Chiu RW, Chow KC, Leung TY, Lau TK, et al. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 2010;56:73-81.
69. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105:16266-71.
70. Chiu RW, Sun H, Akolekar R, Clouser C, Lee C, McKernan K, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010;56:459-63.
71. Makawita S, Diamandis EP. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. Clin Chem 2010;56:212-22.